Global cardiac valvulotome market is estimated to be valued at USD 115.8 Mn in 2024 and is expected to exhibit a CAGR of 4.5% during the forecast period (2024-2031). Cardiac valvulotome is a medical device used in the correction of stenotic cardiac valves. It is a surgical tool inserted through small incisions made in the chest during open-heart surgery. The cardiac valvulotome consists of hollow shafts containing retractable cutting blades that are used to split and dilate narrowed heart valves. It helps restore normal blood flow by enlarging the valve opening. Cardiac valvular stenosis occurs due to the thickening and fusion of valve leaflets over time, restricting their movement and narrowing the passage of blood. Left untreated, it can lead to serious complications like pulmonary edema or heart failure. Cardiac valvulotomy employing a valvulotome is a standard surgical procedure to correct stenosis of the aortic and mitral valves. The valvulotome cuts through the thickened valve tissue, restoring the opening to its normal size. This minimally invasive technique has significantly improved outcomes for patients with severe valve narrowing.
Market Dynamics:
The global cardiac valvulotome market growth is driven by the rising geriatric population who are more prone to age-related valvular diseases. According to the WHO, the number of people aged 65 years and above is projected to reach 1.5 billion by 2050. Furthermore, growing prevalence of rheumatic heart disease in developing nations is also prompting the need for cardiac valvulotome procedures. However, the market growth can be restrained by the development of novel transcatheter valve replacement technologies that provide less invasive treatment options. Alternative procedures like balloon valvuloplasty present stiff competition to traditional cardiac valvulotomy. Nevertheless, valvulotomes continue to remain helpful for correcting mild to moderate valve stenosis. The market sees opportunities from increasing healthcare expenditure and accessibility of cardiac treatments in emerging economies.
Key Features of the Study:
Detailed Segmentation-
Detailed Segmentation-
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients